glp 1 novo nordisk products GLP-1 generics in the US are losing ground without disappearing Novo Nordisk, Eli Lilly cut

In this Huberman Lab episode, my guest is Zachary Knight, Ph.D., a professor of physiology at the University of California, San Francisco (UCSF), and Howard Hughes Medical Institute (HHMI) investigator.

Learn why it happens and how to protect your strength and lean mass while on GLP-1 meds.

Reactions after the first GLP-1 dose

Get Tresiba (insulin degludec) efficacy and safety information for your patients over 1 year of age with type 1 diabetes

Therefore, further research is necessary to fully understand the potential of GLP-1 receptor agonists in providing comprehensive protection against complications related to T2DM.